Products › Human Pharma › Antibiotic
CLAVSAFE 625
क्लैवसेफ 625
CLAVSAFE 625 is a human pharmaceutical antibiotic tablet formulated with amoxycillin 500 mg and clavulanic acid 125 mg. Amoxycillin provides broad-spectrum antibacterial activity, while clavulanic acid acts as a beta-lactamase inhibitor to help preserve amoxycillin activity against susceptible beta-lactamase-producing bacteria. The promotional material identifies use in urinary tract, ENT, skin and soft tissue, post-operative, and respiratory tract infections. It is intended for oral administration and should be used only under the direction of a registered medical practitioner.
Composition
| Ingredient | Strength |
|---|---|
| Amoxycillin | 500 mg |
| Clavulanic Acid | 125 mg |
Benefits
- Provides broad-spectrum antibacterial coverage against susceptible organisms
- Clavulanic acid helps inhibit beta-lactamase enzymes
- Helps maintain amoxycillin activity against susceptible resistant bacteria
Indications
- Urinary tract infections
- ENT infections
- Skin and soft tissue infections
- Post-operative infections
- Respiratory tract infections
- Otitis media
- Lower respiratory tract infections
- Upper respiratory tract infections
Target species
Adults
Pack sizes
10 x 10 tablets
Ordering
CLAVSAFE 625 is supplied in bulk PAN-India by Indo-Safe Healthcare LLP to distributors, veterinary clinics, pharmacies and farms. Request a quotation or contact us at +91 90247 77921.